Search - tctmd.com

Displaying 361 - 380 of 786

Sort: Relevancy | Date

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

May 20, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Industry News

InspireMD to Showcase Embolic Systems with MicroNetTM Technology and Results from MASTER I Trial at EuroPCR Conference

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Yael L. Maxwell

May 20, 2014

News Daily News

CABG Achieves Better 30-Day Outcomes vs PCI in Younger Patients, Similar 5-year Mortality

Yael L. Maxwell

May 15, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Industry News

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

May 13, 2014

News Industry News

Tryton Medical Announces Events at EuroPCR 2014 in Paris

May 12, 2014

News Industry News

Biosensors Announces IDE Approval for BioFreedom™ U.S. Trial

May 05, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

Presentation Fellows 2014

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 12, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

Presentation ACC 2014

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 31, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

Advertisement

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

InspireMD to Showcase Embolic Systems with MicroNetTM Technology and Results from MASTER I Trial at EuroPCR Conference

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

CABG Achieves Better 30-Day Outcomes vs PCI in Younger Patients, Similar 5-year Mortality

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

Tryton Medical Announces Events at EuroPCR 2014 in Paris

Biosensors Announces IDE Approval for BioFreedom™ U.S. Trial

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

Drug-Eluting Stents: Past, Present, and Future

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content